4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines

Lignende værker

• ProtEx™ technology for the generation of novel therapeutic cancer vaccines
  af: Schabowsky, Rich-Henry, et al.
  Udgivet: (2009)
• SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model
  af: Sharma, Rajesh K., et al.
  Udgivet: (2010)
• A Novel Form of 4-1BBL Has Better Immunomodulatory Activity than an Agonistic Anti-4-1BB Ab without Ab Associated Severe Toxicity
  af: Schabowsky, Rich-Henry, et al.
  Udgivet: (2009)
• Correction: SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4(+) T Cells into CD4(+)FoxP3(+) T Regulatory Cells by Production of IFN-γ
  af: Madireddi, Shravan, et al.
  Udgivet: (2012)
• SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4(+) T Cells into CD4(+)FoxP3(+) T Regulatory Cells by Production of IFN-γ
  af: Madireddi, Shravan, et al.
  Udgivet: (2012)